Strata Skin Sciences, Inc. 8-K Filing
Ticker: SSKN · Form: 8-K · Filed: Dec 10, 2025 · CIK: 1051514
| Field | Detail |
|---|---|
| Company | Strata Skin Sciences, Inc. (SSKN) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Strata Skin Sciences, Inc. (ticker: SSKN) to the SEC on Dec 10, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ).
How long is this filing?
Strata Skin Sciences, Inc.'s 8-K filing is 2 pages with approximately 635 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 635 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2025-12-10 16:31:14
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ
Filing Documents
- ef20061034_8k.htm (8-K) — 38KB
- image0.jpg (GRAPHIC) — 209KB
- 0001140361-25-045145.txt ( ) — 685KB
- sskn-20251210.xsd (EX-101.SCH) — 4KB
- sskn-20251210_lab.xml (EX-101.LAB) — 21KB
- sskn-20251210_pre.xml (EX-101.PRE) — 16KB
- ef20061034_8k_htm.xml (XML) — 4KB
07
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS On December 10, 2025 the Company held its annual meeting of stockholders (the "Annual Meeting"). The matters voted upon were: (1) the election of five director nominees to the Company's board of directors to serve until the next annual meeting of the Company's stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal; (2) to approve an amendment to our Amended and Restated 2016 Omnibus Incentive Plan (the "2016 Omnibus Incentive Plan") to increase the number of shares of common stock reserved for issuance thereunder by 520,000 shares; (3) to ratify the selection by the Audit Committee of the Board of Directors of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the voting were as follows: (1) Each of the director nominees to the Company's board of directors was elected: Nominees Votes For Votes Withheld Broker Non-Vote Dr. Uri Geiger 2,208,832 46,203 1,010,399 Dr. Irit Yaniv 2,180,045 74,990 1,010,399 Christina Allgeier 2,180,415 74,620 1,010,399 Shmuel Rubinstein 2,225,313 29,718 1,010,399 Dr. Dolev Rafaeli 2,193,145 61,890 1,010,399 (2) to approve an amendment to the Company's Amended and Restated 2016 Omnibus Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 520,000 shares Votes For Votes Against Abstain Broker Non-Vote 2,158,427 93,484 3,124 1,010,399 (3) to ratify the selection by the Audit Committee of the Board of Directors of CBIZ CPAs P.C. as our independent registered public accounting firm for the Votes For Votes Against Abstain Broker Non-Vote 3,181,648 62,698 21,088 0 -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused th